Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/17/2003WO2003030820A2 Pseudopterosin compounds of symbiodinium spp isolated from pseudopterogorgia elisabethae
04/17/2003WO2003030819A2 Tetracycline derivatives and methods of use thereof
04/17/2003WO2003030816A2 Combinatorial anti-acne compositions
04/17/2003WO2003030814A2 Cross-regulin composition of turmeric-derived tetrahydrocurcuminoids for skin lightening and protection against uvb rays
04/17/2003WO2003030813A2 Anti-irritating rosacea treatment
04/17/2003WO2003030811A2 Use of ganoderic acids as cosmetic agents
04/17/2003WO2003030793A1 Hydrating nasal gel and applicator
04/17/2003WO2003030643A1 Composition and method for treating graft-versus-host disease
04/17/2003WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor
04/17/2003WO2003030615A2 Biocidal mixture of 2-propenal-releasing polymer and isothiazolones
04/17/2003WO2003030612A2 Methods for modulating activity of the fxr nuclear receptor
04/17/2003WO2003020294A8 Aromatase marking
04/17/2003WO2003020259A3 Combinations of dmxaa and other anti-cancer agents
04/17/2003WO2003017927A3 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
04/17/2003WO2003015767A3 Use of tectorigenin for the production of cosmetic or dermatological preparations for the prophylaxis and treatment of inflammatory skin conditions and/or for skin protection of determinate sensitive and dry skin
04/17/2003WO2003014315A3 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs
04/17/2003WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
04/17/2003WO2003011883A3 Process for the preparation of l-ribavirin
04/17/2003WO2003011293A3 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
04/17/2003WO2003008457A3 Polysaccharidic esters of retinoic acid
04/17/2003WO2003007922A3 Pharmaceutical formulation containing an ltb4 antagonist
04/17/2003WO2003006004A3 Pharmaceutical compositions for oral use, containing, in combination, metformin and glicazide, a sulphonyl urea
04/17/2003WO2003005999A3 Methods of treating cytokine mediated diseases
04/17/2003WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
04/17/2003WO2002096903A3 Chemical derivatives and the use thereof as an anti-telomerase agent
04/17/2003WO2002094325A3 Cytotoxic cd44 antibody immunoconjugates
04/17/2003WO2002089770A3 Topical lamellar double membrane structure composition containing n-acyl-ethanolamine and/or a quaternary ammonium salt and/or adenosylmethionine
04/17/2003WO2002083727A3 Nucleic acid sequences of hyperplasies and tumors of the thyroid
04/17/2003WO2002083700A3 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
04/17/2003WO2002079221A3 Sapogenin derivatives, their synthesis and use
04/17/2003WO2002078620A3 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer
04/17/2003WO2002076486A3 Histidine-rich glycoprotein
04/17/2003WO2002076426A3 Intravaginal drug delivery devices for the administration of an antimicrobial agent
04/17/2003WO2002072105A3 Improved prostanoid therapies for the treatment of glaucoma
04/17/2003WO2002069968A8 New use
04/17/2003WO2002067895A3 Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
04/17/2003WO2002065941A3 Method of controlling body temperature
04/17/2003WO2002058707A3 Method of treatment of type i diabetes with vitamin d compounds
04/17/2003WO2002058694A9 Method of treating hematologic tumors and cancers using beta lapachone
04/17/2003WO2002058684A3 Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
04/17/2003WO2002051237A9 Helicobacter proteins, nucleic acids and uses thereof
04/17/2003WO2002050284A3 Oxidoreductases
04/17/2003WO2002041871A3 Composition comprising an imexon or derivatives thereof and lipids
04/17/2003WO2002034206A9 Felodipine transdermal device and methods
04/17/2003WO2002032960A3 Methods of selecting compounds for modulation of bladder function
04/17/2003WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
04/17/2003WO2002032415A3 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells
04/17/2003WO2002024891A3 B7-like molecules and uses thereof
04/17/2003WO2002024181A3 The use of melatonin for induction of general anesthesia
04/17/2003WO2002017881A3 Transdermal pharmaceutical delivery composition
04/17/2003WO2002006523A3 Method for detecting pre-disposition to hepatotoxicity
04/17/2003WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
04/17/2003WO2001094341A9 Quinazoline derivatives for the treatment of tumours
04/17/2003WO2001089494A8 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
04/17/2003WO2001085210A3 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
04/17/2003WO2001078709A3 Treatment of neurodegenerative disease
04/17/2003WO2001076573A3 Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
04/17/2003WO2001074402A3 Camptothecin conjugates
04/17/2003WO2001072752A3 2,3,4,5-TETRAHYDRO-1H-[1,4]DIAZEPINO[1,7-a]INDOLE COMPOUNDS
04/17/2003WO2000037430A3 Use of androgen receptor suppressors
04/17/2003WO2000010990A3 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
04/17/2003WO2000010546A3 D-arginine for the treatment of neorodegenerative diseases
04/17/2003WO2000002548A3 Inhibitors of proteasomal activity for stimulating bone and hair growth
04/17/2003WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands
04/17/2003WO1998003519A3 New bis-platinum complexes with polyamine ligands as antitumor agents
04/17/2003WO1998003518A3 New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity
04/17/2003US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents
04/17/2003US20030073857 26,27-Homologated-20-epi-2-alkyl-19-nor-vitamin D compounds
04/17/2003US20030073852 Anticancer agents
04/17/2003US20030073850 Incontinence; nasal congestion
04/17/2003US20030073849 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
04/17/2003US20030073846 Aminoalcohol derivatives
04/17/2003US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
04/17/2003US20030073843 Methods for preparing CETP inhibitors
04/17/2003US20030073841 New benzo [b] pyrano [3,2-h] acridin-7-one compounds
04/17/2003US20030073837 Anticancer agents
04/17/2003US20030073834 Purine compounds having PDE IV inhibitory activity and methods of synthesis
04/17/2003US20030073833 Antiinflammatory agents; anticoagulants
04/17/2003US20030073829 Nucleotide sequences coding polypeptides for use in the treatment of eating disorders
04/17/2003US20030073826 Crystaline clindamycin free base
04/17/2003US20030073825 Azalide antibiotic compositions
04/17/2003US20030073815 Treatment of brain disorders; obtain adrenic acid or mimetic, administer to human, monitor adjusment in brain disorder
04/17/2003US20030073747 Reversing or preventing premature vascular senescence
04/17/2003US20030073746 Method for treating drug-induced constipation
04/17/2003US20030073745 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
04/17/2003US20030073744 Circadian rhythm disorders; sleep disorders
04/17/2003US20030073743 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
04/17/2003US20030073741 Using N-benzylindolenyacetimide
04/17/2003US20030073740 Using N-benzylindolenyacetimide
04/17/2003US20030073739 Novel arginine/ascorbic acid mixed powder as an oral supplement
04/17/2003US20030073738 Synergistic mixture; anticancer, antitumor agents
04/17/2003US20030073737 Tolerance induction
04/17/2003US20030073734 Condensation derivatives of thiocolchicine and baccatin as antitumor agents
04/17/2003US20030073733 Pharmaceutically active compounds and methods of use
04/17/2003US20030073732 Antiinflammatory agents
04/17/2003US20030073731 Alkylation therapy; anticancer agent
04/17/2003US20030073730 Use of amino-isoxazolidone compounds for treatment of memory impairment following traumatic brain injury
04/17/2003US20030073729 Medicaments for diabetic complication and neuropathy, and uses thereof
04/17/2003US20030073728 Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
04/17/2003US20030073727 Central nervous system disorders
1 ... 5497 5498 5499 5500 5501 5502 5503 5504 5505 5506 5507 5508 5509 5510 5511 5512 5513 5514 5515 5516 5517 ... 7860